Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Bini

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Drug Investigation|August 7, 2024
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in ItalyMartina Paoletti, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|May 7, 2025
Andrea Marcellusi, Chiara Bini, Laura Fioravanti, et al.
Clinical Drug Investigation|August 26, 2018
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic MelanomaFrancesco S Mennini, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|March 16, 2026
The societal costs associated with patients with chronic spontaneous urticaria (CSU) in ItalyChiara Bini, Andrea Marcellusi, Virginia Scansetti, et al.
Global & Regional Health Technology Assessment|September 16, 2024
Chiara Bini, Andrea Marcellusi, Paolo Di Rienzo, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Martina Paoletti, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Andrea Marcellusi, Chiara Bini, Massimo Andreoni, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Human Vaccines & Immunotherapeutics|May 1, 2018
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in ItalyFrancesco Saverio Mennini, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|May 6, 2026
Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in ItalyChiara Bini, Matteo Scortichini, Silvia Ripoli, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Drug Investigation|August 7, 2024
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in ItalyMartina Paoletti, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|May 7, 2025
Andrea Marcellusi, Chiara Bini, Laura Fioravanti, et al.
Clinical Drug Investigation|August 26, 2018
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic MelanomaFrancesco S Mennini, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|March 16, 2026
The societal costs associated with patients with chronic spontaneous urticaria (CSU) in ItalyChiara Bini, Andrea Marcellusi, Virginia Scansetti, et al.
Global & Regional Health Technology Assessment|September 16, 2024
Chiara Bini, Andrea Marcellusi, Paolo Di Rienzo, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Martina Paoletti, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Andrea Marcellusi, Chiara Bini, Massimo Andreoni, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Chiara Bini, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Human Vaccines & Immunotherapeutics|May 1, 2018
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in ItalyFrancesco Saverio Mennini, Chiara Bini, Andrea Marcellusi, et al.
Global & Regional Health Technology Assessment|May 6, 2026
Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in ItalyChiara Bini, Matteo Scortichini, Silvia Ripoli, et al.
Pageof 3